Orbimed Advisors LLC Jazz Pharmaceuticals PLC Transaction History

Orbimed Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $102 Million - $147 Million	-884,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$161.01 - $180.57 $25.1 Million - $28.2 Million	-156,100 Reduced 15.01%	884,000 $149 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $58.6 Million - $67.9 Million	432,200 Added 71.1%	1,040,100 $157 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $18.5 Million - $21.3 Million	-141,300 Reduced 18.86%	607,900 $81.9 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $107 Million - $117 Million	749,200	749,200 $110 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.7B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.